LSD Microdosing

Australian biopharma company MindBio Therapeutics Corp. has shared positive topline results from its completed take-home microdosing clinical trial on major depressive disorder.  The treatment provided to the 20 participants is MB22001, the company's microdose formulation of a self-titratable...

(See Part 1: Exclusive Insights: How Tech Leaders Are Finding Balance Through Microdosing Psychedelics) Paul Austin, the trainer of psychedelics microdosing practitioners, spoke to Benzinga about his collaboration with Lauren Mugglebee, who transitioned from a career at Meta  (NASDAQ: META)...

A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances with that of classic drugs.  It further eliminates the criteria based on the number of...

Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics committee and the Clinical Trials Registry to begin the world's first Phase 2a take-home LSD microdosing trial in patients with Major Depressive Disorder (MDD). MDD is reportedly the leading cause...